Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Opthea ( (AU:OPT) ) has shared an update.
Opthea Limited has released a corporate update through an investor presentation dated August 19, 2025. The presentation provides a summary of the company’s current activities and emphasizes that it is not a comprehensive source of information for investment decisions. The update includes market and industry data from third-party sources, which have not been independently verified by Opthea. The presentation also contains forward-looking statements that involve risks and uncertainties, cautioning investors against placing undue reliance on them. The company stresses that the presentation is for informational purposes only and not financial advice.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited is a company listed on the Australian Securities Exchange (ASX:OTP) that operates in the biotechnology industry. The company focuses on developing therapies for the treatment of eye diseases, particularly targeting conditions like wet age-related macular degeneration.
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
See more insights into OPT stock on TipRanks’ Stock Analysis page.